Results 111 to 120 of about 130,828 (352)

Clinical efficiency of transfusion of pathogen-inactivated platelet concentrates

open access: yesТерапевтический архив, 2013
AIM: To evaluate the effect of pathogen-inactivated platelet concentrates (PIPC) on posttransfusion platelet increments, hemorrhagic syndrome relief, and transfusion intervals/MATERIAL AND METHODS: This prospective study included 29 hemoblastosis ...
I M Nakastoev   +9 more
doaj  

Neonatal Thrombocytopenia: Diagnostic Approach and Platelet Transfusion Guideline

open access: yesClinical Pediatric Hematology-Oncology, 2019
Neonatal thrombocytopenia, defined as platelet counts of less than 150,000/µL, is a frequent hematologic abnormality in neonatal period. Differential diagnosis of neonatal thrombocytopenia may be challenging to pediatric hematologists and neonatologists ...
Ji Sook Kim, Ji Yoon Kim
doaj   +1 more source

Data from differentially expressed proteins in platelet components associated with adverse transfusion reactions

open access: yesData in Brief, 2019
The presented dataset was used for the study focused on the search for differentially expressed proteins in blood platelet components (PCs) associated with adverse transfusion reactions (ATRs).
Chaker Aloui   +7 more
doaj   +1 more source

Efficacy of platelet-rich plasma as conservative treatment in orthopaedics. a systematic review and meta-analysis [PDF]

open access: yes, 2018
Background. The aim of this systematic review and meta-analysis was to evaluate the benefit of platelet-rich plasma (PRP) in non-surgical orthopaedic procedures. Material and methods. We searched the Cochrane Wounds Specialized Register, CENTRAL, MEDLINE
Cruciani, Mario   +9 more
core   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre   +5 more
wiley   +1 more source

Rituximab induced pulmonary edema managed with extracorporeal life support [PDF]

open access: yes, 2018
Though rare, rituximab has been reported to induce severe pulmonary edema. We describe the first report of ECLS utilization for this indication. A 31-year-old female with severe thrombotic thrombocytopenic purpura developed florid pulmonary edema after ...
Aguilar, Patrick   +6 more
core   +3 more sources

Bionic nanobombs target nasopharyngeal carcinoma to enhance the efficacy of chemoradiotherapy by destroying DNA damage repair systems

open access: yesVIEW, EarlyView.
A bionic nanomedicine system with core–shell structure (Nm‐pAu/CP/KU) was constructed. PEGylated gold nanoparticles (pAu) were loaded with cisplatin (CP) and a radiochemotherapy sensitizer (KU‐60019) to form the core pAu/CP/KU, and homologous nasopharyngeal carcinoma cell membrane vesicles (Nm) were used as the shell.
Junhua Zhang   +4 more
wiley   +1 more source

Towards the Development of a Conceptual Framework of the Determinants of Pre‐Eclampsia: A Hierarchical Systematic Review of Social Determinants

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Existing reviews of pre‐eclampsia determinants have focused on clinical and genetic risk factors. Objective To evaluate social determinants for pre‐eclampsia prevention. Search Strategy Systematic searches were conducted from relevant electronic databases from inception of each database to 30th December 2024.
Mai‐Lei Woo Kinshella   +16 more
wiley   +1 more source

Platelet Transfusion Refractoriness

open access: yesPlasmatology
Platelet transfusion refractoriness (PTR) is a conditioikb1n where platelet counts fail to increase adequately in several transfusions, often found in hemato-oncological situations.
Anna Mira Lubis MD   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy